Participated · Series A · Jul 2026

Founded in 2020 in Toulouse, Bohr Énergie operates a proprietary platform that combines software, AI, algorithms, production forecasting, market analysis and regulatory expertise to enable optimisation and commercialisation of distributed renewable and flexible assets. As an independent aggregator it manages solar, wind, hydro, batteries and hybrid systems, enabling asset owners to participate in electricity markets. The firm currently has more than 170 renewable and flexible assets in its portfolio and expects to reach close to 1 GW under management by the end of the year. Management plans to use the Series A capital to consolidate its French position, accelerate platform development and launch additional services. Bohr has signalled international expansion with Spain and Italy among its priority markets.

Participated · Seed · Jul 2026

TaiSan operates out of a Cambridge battery lab and develops next-generation sodium batteries it says are more efficient than existing sodium-ion and lithium-ion rivals. The company targets applications including electric bikes, scooters, vehicles and power tools. Founded and led by Sanzhar Taizhan, a former Kazakhstani chess champion, TaiSan has kept several breakthroughs in stealth while progressing its electrochemistry. Financially, the startup has raised €1.7M in pre-seed funding and has just closed a £4.65M seed round that includes a £700,000 Innovate UK grant. TaiSan plans to use the new capital to enhance battery performance and begin pilot testing with manufacturers. The company intends to bring its sodium-battery benefits to a mainstream audience.

Participated · Seed · May 2026

NEX Health Intelligence builds predictive analytics intended to identify where drug‑resistant infections are likely to spread inside hospitals. The company’s technology is described as forecasting in-hospital transmission of antimicrobial‑resistant infections. TFN reported that NEX Health Intelligence raised €1M in new funding. The article does not provide revenue, user, or other operating metrics. No information on valuation, investor identities, or prior funding rounds was disclosed in the report.

Led · Equity · Mar 2026

DiappyMed builds a digital therapy designed to personalize insulin dose calculations for people with type 1 or type 2 diabetes treated with a basal/bolus regimen. The company presents its solution as the first French therapy numérique dedicated to individualized insulin dosing and says it works with professionals de santé and patients. DiappyMed announced a strategic partnership with Sanofi to enable broad deployment of the therapy across France. The company aims to secure reimbursement from Assurance Maladie by 2026 and frames the recent financing and partnership as steps toward that objective. In support of its rollout, DiappyMed raised €5 million in an amorçage round led by Ventech and AFI Ventures with participation from SOFILARO/CALEN and IRDI Capital Investissement, and cited additional institutional partners and supporters. No revenue, user metrics, founding year, or valuation were disclosed in the available articles.

Led · Seed · Mar 2026

Blify develops an AI-native Learning Operating System that embeds training directly into workplace communication tools such as Slack, Microsoft Teams and WhatsApp. Its solution uses a multi-agent AI infrastructure to analyze contextual information about employees and their roles to deliver relevant knowledge at the right moment within existing workflows. The founders—Clément Lhommeau, Tristan Vié, and Minh-Tu Hua—draw on HR tech and European SaaS experience to design the product. Blify plans to spend 2025 developing and testing a manager-training use case before launching a broader platform in 2026 for creating, distributing, and managing company-wide training. The company recently raised $2.1 million in pre-seed funding to accelerate product development and expand its engineering team.